Person who experienced the adverse event (patient)
| Event ID | CASE | I F COD | FOLL SEQ | IMAGE | EVENT DT | MFR DT | FDA DT | REPT COD | MFR NUM | MFR SNDR | AGE | AGE COD | GNDR COD | E SUB | WT | WT COD | REPT DT | OCCP COD | DEATH DT | TO MFR | CONFID | REPORTER COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 5159264 | 6167343 | F | 1 | 5159264-1 | 20061004 | 20061113 | 20061120 | EXP | 2006SP003991 | SCHERING-PLOUGH CORPORATION | 58 | YR | M | N | 58 | KG | 20061117 | MD | 20061004 | JAPAN |
Drug(s) used by person
| Event ID | DRUG SEQ | ROLE COD | DRUGNAME | VAL VBM | ROUTE | DOSE VBM | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 5159264 | 1007887373 | PS | PEG-INTRON | 1 | SUBCUTANEOUS | 80 MCG, QW; SC; 40 MCG, QW; SC | D | D | |||
| 5159264 | 1007917699 | SS | REBETOL | 1 | ORAL | 200 MG; QD; PO | D | D | |||
| 5159264 | 1007917703 | C | ADALAT (PREV.) | 2 | |||||||
| 5159264 | 1007917704 | C | CARDENALIN (PREV.) | 2 | |||||||
| 5159264 | 1007917705 | C | RENIVACE | 2 | |||||||
| 5159264 | 1007917707 | C | BASEN | 2 |
Indications of drugs used
| Event ID | DRUG SEQ | INDI PT |
|---|---|---|
| 5159264 | 1007887373 | HEPATITIS C |
| 5159264 | 1007917699 | HEPATITIS C |
Outcome of event
| Event ID | OUTC COD |
|---|---|
| 5159264 | DE |
Reactions reported
| Event ID | PT |
|---|---|
| 5159264 | NEUTROPHIL COUNT DECREASED |
| 5159264 | PLATELET COUNT DECREASED |
| 5159264 | WHITE BLOOD CELL COUNT DECREASED |
Reporting Sources (this data is often not reported and may therefore be missing here)
| Event ID | RPSR COD |
|---|---|
| 5159264 | CR |
| 5159264 | FGN |
| 5159264 | HP |
Therapies reported
| Event ID | DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|
| 5159264 | 1007887373 | 20060904 | 20060904 | ||
| 5159264 | 1007887373 | 20060913 | |||
| 5159264 | 1007917699 | 20060914 |